Know Cancer

or
forgot password


Phase 2
30 Years
70 Years
Open (Enrolling)
Both
Pancreatic Tubular Adenocarcinoma

Thank you

Trial Information


Inclusion Criteria:



- ECOG performance status 0-2 at the time of inclusion

- Following R0 or R1 pancreatic tubular adenocarcinoma resection and adjuvant
gemcitabine treatment

Exclusion Criteria:

- Pregnancy

- Less than 3 mths expected survival

- Serious comorbidity

- Age above 70 yrs

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

PROGRESSION FREE SURVIVAL

Outcome Time Frame:

1 YEAR

Safety Issue:

No

Authority:

Slovenia: Agency for Medicinal Products and Medical Devices of the Republic of Slovenia

Study ID:

MIS

NCT ID:

NCT01021800

Start Date:

April 2009

Completion Date:

December 2012

Related Keywords:

  • Pancreatic Tubular Adenocarcinoma
  • Pancreatic tubular adenocarcinoma adjuvant setting
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous

Name

Location